A detailed history of Alps Advisors Inc transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 64,692 shares of AVIR stock, worth $206,367. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,692
Previous 65,678 1.5%
Holding current value
$206,367
Previous $217,000 0.46%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.17 - $4.02 $3,125 - $3,963
-986 Reduced 1.5%
64,692 $216,000
Q2 2024

Aug 13, 2024

BUY
$3.31 - $4.04 $20,889 - $25,496
6,311 Added 10.63%
65,678 $217,000
Q1 2024

May 14, 2024

BUY
$3.09 - $4.56 $2,876 - $4,245
931 Added 1.59%
59,367 $239,000
Q4 2023

Feb 14, 2024

SELL
$2.8 - $3.35 $8,783 - $10,508
-3,137 Reduced 5.09%
58,436 $178,000
Q3 2023

Nov 14, 2023

BUY
$3.0 - $3.79 $813 - $1,027
271 Added 0.44%
61,573 $184,000
Q2 2023

Aug 14, 2023

BUY
$3.21 - $5.06 $20,527 - $32,358
6,395 Added 11.65%
61,302 $229,000
Q1 2023

May 10, 2023

SELL
$3.0 - $4.97 $5,115 - $8,473
-1,705 Reduced 3.01%
54,907 $183,000
Q4 2022

Feb 14, 2023

BUY
$4.35 - $6.17 $246,262 - $349,296
56,612 New
56,612 $272,000

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $266M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.